Semin Liver Dis 2005; 25(2): 226-229
DOI: 10.1055/s-2005-871201
DIAGNOSTIC PROBLEMS IN HEPATOLOGY

Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Hepatocellular Carcinoma in Type 1 Gaucher Disease: A Case Report with Review of the Literature

Ruliang Xu1 , Pramod Mistry3 , Gregg Mckenna2 , Sukru Emre2 , Thomas Schiano2 , Moueen Bu-Ghanim1 , Gabriel Levi1 , Maria Isabel Fiel1
  • 1Lillian and Henry M. Stratton- Hans Popper Department of Pathology, Division of Hepatopathology, New York, New York
  • 2Recanati-Miller Transplantation Institute, Mount Sinai Medical Center, New York, New York
  • 3Department of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut
Further Information

Publication History

Publication Date:
25 May 2005 (online)

Gaucher disease is a rare inborn error of metabolism but represents the most common type of lysosomal storage disease, and it is highly prevalent in the Ashkenazi Jewish population. It is an autosomal recessive disorder caused by deficiency of glucocerebrosidase, which results in accumulation of glucosyl ceramide in the lysosomes of tissue macrophages. The resulting phenotype is complex, involving hepatosplenomegaly, marrow infiltration, and diverse patterns of skeletal and pulmonary disease. The majority of patients (99%) have non-neuronopathic disease (type 1), but the brain is involved in neuronopathic types 2 and 3 of the disease. The standard of care for type 1 Gaucher disease is enzyme supplemental therapy with macrophage-targeted, recombinant glucocerebrosidase (imiglucerase).

Several reports indicate development of a variety of neoplasms including malignancies, especially hematologic, in patients with type 1 Gaucher disease.[1] As with other inborn errors of metabolism affecting the liver that lead to an increased risk of hepatocellular carcinoma (HCC), there has been speculation that Gaucher disease may increase the risk of malignancies in organs that are involved in the accumulation of the storage cells. The liver is universally involved in type 1 Gaucher disease and there are reports of the development of cirrhosis and an unusual type of fibrosis necessitating liver transplantation, although the hepatocytes, per se, do not appear to be involved in the storage process.[2] [3] Interestingly, HCC has also been reported in two patients with type 1 Gaucher disease.[4] [5] Herein, we report a third case of HCC in type 1 Gaucher disease that was managed successfully with liver transplantation and continued enzyme replacement therapy.

REFERENCES

  • 1 Shiran A, Brenner B, Laor A, Tatarsky I. Increased risk of cancer in patients with Gaucher disease.  Cancer. 1993;  72 219-224
  • 2 James S P, Stromeyer F W, Chang C, Barranger J A. Liver abnormalities in patients with Gaucher's disease.  Gastroenterology. 1981;  80 126-133
  • 3 Lachmann R H, Wight D G, Lomas D J et al.. Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features.  QJM. 2000;  93 237-244
  • 4 Breiden-Langen C M, Buchsel R, Brambs H J, Oehlert M, Matern S. Coincidence of Gaucher disease with primary hepatocellular carcinoma.  Leber Magen Darm. 1991;  21 126 129-130
  • 5 Erjavec Z, Hollak C E, de Vries E G. Hepatocellular carcinoma in a patient with Gaucher disease on enzyme supplementation therapy.  Ann Oncol. 1999;  10 243
  • 6 Bohm P, Kunz W, Horny H P, Einsele H. Adult Gaucher disease in association with primary malignant bone tumors.  Cancer. 2001;  91 457-462
  • 7 Chang-Lo M, Yam L T, Rubenstone A I, Schwartz S O. Gaucher's disease associated with chronic lymphocytic leukaemia, gout and carcinoma.  J Pathol. 1975;  116 203-207
  • 8 Davis M, Dorfman J. Gaucher's disease associated with a cerebral astrocytoma. A case report involving an adult.  Am Pract Dig Treat. 1961;  12 673-677
  • 9 Gupta M K, Levin M, Aguilera N S, Pastores G M. Littoral cell angioma of the spleen in a patient with Gaucher disease.  Am J Hematol. 2001;  68 61-62
  • 10 Kenan S, Abdelwahab I F, Hermann G, Klein M, Pastores G. Osteoblastoma of the humerus associated with type-I Gaucher's disease. A case report.  J Bone Joint Surg Br. 1996;  78 702-705
  • 11 Kojiro M, Kage M, Abe H, Imamura M, Shiraishi K, Mizoguchi M. Association of dysgerminoma and Gaucher's disease.  Cancer. 1983;  51 712-715
  • 12 Lyons J C, Scheithauer B W, Ginsburg W W. Gaucher's disease and glioblastoma multiforme in two siblings: a clinicopathologic study.  J Neuropathol Exp Neurol. 1982;  41 45-53
  • 13 Pins M R, Mankin H J, Xavier R J, Rosenthal D I, Dickersin G R, Rosenberg A E. Malignant epithelioid hemangioendothelioma of the tibia associated with a bone infarct in a patient who had Gaucher disease. A case report.  J Bone Joint Surg Am. 1995;  77 777-781
  • 14 Tsung S H, Cotes E. Coexistence of bronchogenic carcinoma and Gaucher disease.  Arch Pathol Lab Med. 1977;  101 56
  • 15 Watanabe M, Yanagisawa M, Sonobe S, Matsumoto J, Miura H. An adult form of Gaucher's disease with a huge tumour formation of the right tibia.  Int Orthop. 1984;  8 195-202
  • 16 Bertram H C, Eldibany M, Padgett J, Dragon L H. Splenic lymphoma arising in a patient with Gaucher disease. A case report and review of the literature.  Arch Pathol Lab Med. 2003;  127 242-245
  • 17 Gal R, Gukovsky-Oren S, Floru S, Djaldetti M, Kessler E. Sequential appearance of breast carcinoma, multiple myeloma and Gaucher's disease.  Haematologica. 1988;  73 63-65

Ruliang XuM.D. Ph.D. 

The Lillian and Henry M. Stratton- Hans Popper Department of Pathology, Mount Sinai School of Medicine

One Gustave L. Levy Place

New York, NY 10029

Email: ruliang.xu@msnyuhealth.org

    >